Report Summary
- The global market for congestive heart failure devices was $3.1 billion in 2010. This global market reached $3.4 billion in 2011 and is expected to grow to $5.9 billion by 2016, a compound annual growth rate (CAGR) of 11.7%.
- The American market for congestive heart failure devices accounted for nearly 52.5% of the market in 2010 and was valued at $1.6 billion. This market is expected to reach $1.8 billion in 201 and BCC anticipates that the market will approach $3.2 billion by 2016, a CAGR of 12.4%.
- In the Americas, ventricular assist devices (VAD) were the leading revenue generator with $761.5 million in 2011 and an expected $1.3 billion in 2016. VADs secured 43% of the market in 2011 and will continue to command 42% market share in 2016.
INTRODUCTION
STUDY GOALS AND OBJECTIVES
The objectives of the study are to present a comprehensive look at the devices for treating congestive heart failure (CHF) provide global market measurements of both the overall market and all possible market segments, and to forecast market and segment growth over the next 5 years. This is the second report in the complete coverage of congestive heart failure. The first report, Drugs for Treating Congestive Heart Failure: Global Markets, is available from BCC Research.
REASONS FOR STUDY
This BCC study is presented to increase the awareness of devices to treat congestive heart failure. The study analyzes select devices for treating the congestive heart failure global market from different standpoints and addresses issues and trends affecting the market. Congestive heart failure drug manufacturers, driven by both research breakthroughs and increased recognition of expanding market opportunities, have stepped up the pace of development of innovative products. Because of the evolving nature of this important area of study, executives of product development for congestive heart failure devices must remain ever vigilant of the changing environment and strive to keep abreast of new and currently used modalities in all facets of the market.
SCOPE OF STUDY
This report is a comprehensive business tool designed to provide an in-depth look at devices for the congestive heart failure market. The geographic scope of the report is global with a special emphasis on individual regions. The report describes the industry, its relationship to the healthcare industry and its participants, and trends for the future.
Categories discussed in the report include:
- Ventricular Assist Devices
- Implantable Cardioverter Defibrillators
- Pacemakers
- Others and Total Artificial Hearts.
All categories are discussed in detail, describing each segment, identifying current products on the market, measuring market size, identifying market drivers, forecasting for 2011 to 2016, and assessing the competitors and competitor market shares.
Americas Congestive Heart Failure Devices Markets
Published: January 2012
No.OF Pages: 97
Price: Single User License – US$ 3900 Corporate User License US$ 6835
Table Of Contents
Chapter- 1: INTRODUCTION – Complimentary 3
STUDY GOALS AND OBJECTIVES
REASONS FOR STUDY
SCOPE OF STUDY
METHODOLOGY AND INFORMATION SOURCES
ANALYST CREDENTIALS
RELATED BCC REPORTS
BCC ON-LINE SERVICES
DISCLAIMER
Chapter- 2: EXECUTIVE SUMMARY 3
Table: GLOBAL MARKET FOR CONGESTIVE HEART FAILURE DEVICES, THROUGH 2016
Figure: TOTAL GLOBAL MARKET FOR CONGESTIVE HEART FAILURE DEVICES, 2010-2016
Chapter- 3: OVERVIEW 24
ETIOLOGY
TREATMENTS
TREATMENT DEVICES
Chapter- 4: RESEARCH AND DEVELOPMENT 5
COUNTERPULSATION DEVICE
LILLEHEI E.V.A.
WIRELESS SENSOR, CARDIOMEMS
MYOCELL, BIOHEART
COAPSYS, MYOCOR
MITIHEART LVAD, MITIHEART
TOTAL ARTIFICIAL HEART, SYNCARDIA SYSTEMS
SYNERGY POCKET MICRO-PUMP, CIRCULITE
EVAHEART LVAS, EVAHEART MEDICAL
GRNCM1, GERON
SMARTHEART LVAD AND SMARTHEART TAH, CLEVELAND HEART
Table: PIPELINE DEVICES AND TECHNOLOGY
Chapter- 5: GLOBAL MARKET SIZE AND GROWTH 10
GROWTH BY GEOGRAPHIC REGION
GROWTH BY TREATMENT TYPE
COMPETITIVE ANALYSIS
Table: TOTAL GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET COMPETITIVE ANALYSIS, 2011
Figure: TOTAL GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET COMPETITIVE ANALYSIS BY PERCENT
Table: GLOBAL CONGESTIVE HEART FAILURE MANUFACTURER PRODUCT PARTICIPATION BY DEVICE TYPE
Chapter- 6: THE AMERICAS MARKET 26
UNITED STATES
CANADA
LATIN AND SOUTH AMERICA
AMERICAS ELDERLY POPULATION
AMERICAS MARKET SIZE AND GROWTH OF THE CHF MARKET
Table: AMERICAS MARKET BY GEOGRAPHIC REGION, THROUGH 2016
Figure: TOTAL AMERICAS MARKET BY GEOGRAPHIC REGION, 2011
Figure: TOTAL AMERICAS MARKET BY GEOGRAPHIC REGION, 2016
Table: TOTAL AMERICAS MARKET SIZE OF CONGESTIVE HEART FAILURE MARKET REVENUE BY TREATMENT DEVICE TYPE AT MANUFACTURERS’ SALES LEVELS, THROUGH 2016
Table: TOTAL AMERICAS CHF MARKET SHARE BY DEVICE TYPE, 2011
Figure: TOTAL AMERICAS CHF MARKET SHARE BY DEVICE TYPE, 2011
Table: TOTAL AMERICAS CHF MARKET SHARE BY DEVICE TYPE, 2016
Figure: TOTAL AMERICAS CHF MARKET TREATMENT SHARE BY DEVICE TYPE, 2016
Table: U.S. REGIONAL REVENUE BREAKDOWN BY TREATMENT DEVICE TYPE THROUGH 2016
Table: CANADA REGIONAL REVENUE BREAKDOWN BY DEVICE TYPE, THROUGH 2016
Table: LATIN AMERICA/SOUTH AMERICA REGIONAL REVENUE BREAKDOWN BY DEVICE TYPE, THROUGH 2016
Chapter- 7: COMPANY PROFILES 17
ABIOMED
BERLIN HEART, INC.
BIOHEART, INC.
BIOTRONIK
BOSTON SCIENTIFIC
HEARTWARE INTERNATIONAL, INC.
JARVIK HEART
MEDTRONIC, INC.
MICROMED CARDIOVASCULAR, INC.
ST JUDE MEDICAL, INC.
TELEFLEX, INC.
THORATEC
WORLD HEART CORPORATION
Chapter- 8: APPENDIX: OTHER CHF DEVICE COMPANIES 9
APPENDIX
List of Tables and Figures